Windtree Therapeutics (WINT) Projected to Post Earnings on Wednesday

Windtree Therapeutics (NASDAQ:WINT) is anticipated to announce its Q4 2025 results after the market closes on Wednesday, April 8th. Analysts expect the company to announce earnings of $18.00 per share and revenue of $3.80 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Wednesday, April 15, 2026 at 12:30 PM ET.

Windtree Therapeutics Stock Up 12.6%

WINT opened at $0.01 on Tuesday. Windtree Therapeutics has a 12-month low of $0.01 and a 12-month high of $1.86. The stock has a market cap of $521,860.80, a price-to-earnings ratio of 0.00 and a beta of 0.67. The business has a 50 day moving average of $0.01 and a 200-day moving average of $0.05.

About Windtree Therapeutics

Windtree Therapeutics, Inc is a clinical-stage biotechnology company developing innovative therapies for acute cardiovascular and pulmonary conditions. The company leverages its proprietary KL4 surfactant technology to address diseases marked by surfactant deficiency or dysfunction, with a primary focus on acute respiratory distress syndrome (ARDS) in adults and respiratory distress syndrome (RDS) in premature infants.

The company’s lead platform comprises synthetic peptide‐based surfactants designed to restore lung function by reducing surface tension in the alveoli.